Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results

  • Darell D. Bigner
  • , Mark T. Brown
  • , Allan H. Friedman
  • , R. Edward Coleman
  • , Gamal Akabani
  • , Henry S. Friedman
  • , Wade L. Thorstad
  • , Roger E. McLendon
  • , Sandra H. Bigner
  • , Xiao Guang Zhao
  • , Charles N. Pegram
  • , Carol J. Wikstrand
  • , James E. Herndon
  • , Nicholas A. Vick
  • , Nina Paleologos
  • , Ilkcan Cokgor
  • , James M. Provenzale
  • , Michael R. Zalutsky

Research output: Contribution to journalArticlepeer-review

173 Scopus citations

Fingerprint

Dive into the research topics of 'Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science